AzTrials
AzTrials

Traumatic Brain InjuriesNCT07867119

Therapeutic Benefits of Pareidolia in Acute Traumatic Brain Injury Patients

A study testing Therapeutic Benefits of Pareidolia and Active Comparator #1 in people with Traumatic Brain Injuries, run by Shirley Ryan AbilityLab at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study will investigate whether viewing and identifying meaningful shapes or images hidden within nature pictures (pareidolia) can improve motivation and engagement in rehabilitation therapy for adults with mild to moderate traumatic brain injury (TBI). Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Traumatic Brain Injuries
What is being tested?
Therapeutic Benefits of Pareidolia and Active Comparator #1
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteUnited States
Study dates
10 Oct 2026to 24 Aug 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of mild-to-moderate traumatic brain injury (TBI) based on hospital chart review.
  • Age 18 to 80 years. Premorbidly fluent in English. Education level greater than 8th grade. Corrected visual acuity of at least 20/40.
  • -

Who cannot join

  • Other neurological disorders affecting cognition or language, active substance use, epilepsy, history of psychosis or schizophrenia, hemianopia, severe spatial neglect, isolation precautions, severe visual impairment.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Sameer A Ashaie, PhD contact

3122386154

sashaie@sralab.org

Brook Boxrud contact

United States1 site
  • Shirley Ryan Ability Lab

    Chicago, Illinois, 60610

Other trials in United States

About this study

This study will investigate whether viewing and identifying meaningful shapes or images hidden within nature pictures (pareidolia) can improve motivation and engagement in rehabilitation therapy for adults with mild to moderate traumatic brain injury (TBI). Participants will be randomly assigned to either a pareidolia-based activity group or a control group and will complete therapy sessions and assessments over approximately three weeks. The findings may help identify a simple, low-risk approach to enhancing rehabilitation participation after TBI

Read the detailed description

This study examines whether pareidolia, the experience of seeing meaningful images or patterns in ambiguous visual stimuli (such as faces in clouds), can improve motivation and engagement during rehabilitation therapy for adults with mild to moderate traumatic brain injury (TBI). Approximately 50 participants receiving inpatient rehabilitation at Shirley Ryan AbilityLab will be randomly assigned to either a pareidolia intervention group, which will participate in a guided scavenger hunt using nature images containing hidden pareidolic patterns, or a control group that will view similar nature images without searching for hidden shapes. Over a 3-week period, participants will complete 4 to 6 intervention sessions along with pre- and post-study assessments measuring motivation, therapy engagement, mood, anxiety, apathy, and, in some cases, eye-movement patterns. The study involves minimal risk, primarily mild fatigue or frustration during activities, and while participants may not directly benefit, the findings may help identify a simple, low-risk approach to enhancing participation and engagement in rehabilitation therapy for individuals recovering from TBI.

Being tested
Therapeutic Benefits of Pareidolia, Active Comparator #1
Keywords
TBI, Depression, Mood, Engagement, Anxiety, Pareidolia
Medical subject headings
Brain Injuries, Traumatic, Depression, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Therapeutic Benefits of PareidoliaBehavioural

    A clinician-guided pareidolia intervention in which participants identify and describe meaningful shapes or images embedded within nature-based visual stimuli during structured rehabilitation sessions. The activity is delivered as a progressive scavenger hunt with varying levels of image difficulty.

  • Active Comparator #1Behavioural

    Participants complete a comparable walking and nature-image viewing activity without pareidolic images or instructions to identify hidden shapes or patterns.

Study groups in NCT07867119
Study groupRoleWhat they receive
Structured pareidolia-based therapeutic activity.ExperimentalParticipants complete a structured pareidolia scavenger hunt involving identification of hidden images and shapes within nature-based pictures during rehabilitation sessions.
Receives: Behavioral: Therapeutic Benefits of Pareidolia
Nature-image viewing activity without pareidolia exposure.Active comparatorParticipants complete a comparable walking and nature-image viewing activity without pareidolic images or instructions to search for hidden shapes.
Receives: Behavioral: Active Comparator #1

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Therapy Engagement

    Therapy Engagement and Motivation as measured by the Rehabilitation Therapy Engagement Scale (RTES)

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Oct 2026
  2. Study start10 Oct 2026 (estimated)
  3. Primary completion24 Aug 2029 (estimated)
  4. Study completion24 Aug 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07867119
Sponsor's protocol ID
STU00225776
Status last verified
Aug 2026
First submitted
5 Oct 2026
Last updated
9 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: We have not decided in what format to share the data and whether to share summary or individual data.

Questions about this trial

What is this clinical trial studying?

A study testing Therapeutic Benefits of Pareidolia and Active Comparator #1 in people with Traumatic Brain Injuries, run by Shirley Ryan AbilityLab at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sameer A Ashaie, PhD (3122386154, sashaie@sralab.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Therapy Engagement (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in